Analysis

Compass Pathways 2025 Financial Review

Compass Pathways 2025 Financial Review

Company Overview Compass Pathways plc is a biotechnology company developing COMP360, an investigational synthetic psilocybin therapy for mental health conditions…

LENZ Therapeutics Q4 FY 2025 Financial Update

Company Overview LENZ Therapeutics is a pharmaceutical company focused on the commercialization of VIZZ (aceclidine ophthalmic solution) 1.44% for the…

Neurogene Inc. Full Year 2025 Financial Overview

Neurogene is a clinical-stage biotechnology company focused on developing genetic medicines for individuals and families affected by rare neurological diseases.…

Velo3D 2025 Financial Performance Review

Velo3D, Inc. is an additive manufacturing technology company that transforms aerospace and defense supply chains with metal 3D printing. Full-year…

Fennec Pharmaceuticals 2025 Financial Update

Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company committed to the fight against ototoxicity in cancer patients. The company recently…

NVIDIA (NVDA) Re-Entry Into China’s AI Chip Market: Products, Policy, Competition, and Investor Impact

NVIDIA (NVDA) is positioning for a potential re-acceleration of data center growth by adapting its AI accelerator lineup for China…

Avalo Therapeutics 2025 Financial Review

Avalo Therapeutics is a clinical-stage biotechnology company dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases. The company's lead asset,…

WeRide Inc. 2025 Financial Performance Review

WeRide Inc. is a global leader in autonomous driving technology and the first publicly traded robotaxi company. For the full…

Surrozen 2025 Financial Results Review

Surrozen is a biotechnology company developing targeted therapeutics that harness Wnt signaling to address sight-threatening ophthalmic conditions. For the full…

PPHC Q4 and FY 2025 Financial Review

Public Policy Holding Company, Inc. (PPHC) is a global strategic communications provider offering advisory services across Government Relations, Corporate Communications,…